Vimta Labs Ltd. — Investor Relations & Filings
Vimta Labs Ltd. is a contract research and testing organization providing comprehensive scientific services across multiple sectors. The company specializes in analytical testing, clinical research, preclinical studies, and environmental monitoring. Its service portfolio includes pharmaceutical analysis, biopharmaceutical characterization, food safety testing, and diagnostic services. Vimta operates advanced laboratory facilities equipped to handle complex regulatory requirements, including compliance with global standards such as GLP, GCP, and ISO. The organization supports the life sciences, food, and electronics industries by offering specialized services like molecular biology, microbiology, and toxicology assessments. By integrating multi-disciplinary expertise, the company facilitates product development, quality control, and safety evaluations for a global clientele.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Investor Call Transcript- FY 2025-26- Q4 Earnings/ Investor Call held on 06th May 2026 | 2026-05-12 | English | |
| Analysts/Institutional Investor Meet/Con. Call Updates | 2026-05-12 | English | |
| Copy of Newspaper Publication | 2026-05-07 | English | |
| Analysts/Institutional Investor Meet/Con. Call Updates | 2026-05-06 | English | |
| Change in Director(s) | 2026-05-06 | English | |
| Record Date | 2026-05-06 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 45272164 | Investor Call Transcript- FY 2025-26- Q4 Earnings/ Investor Call held on 06th May 2026 | 2026-05-12 | English | ||
| 45261702 | Analysts/Institutional Investor Meet/Con. Call Updates | 2026-05-12 | English | ||
| 42965355 | Copy of Newspaper Publication | 2026-05-07 | English | ||
| 42163555 | Analysts/Institutional Investor Meet/Con. Call Updates | 2026-05-06 | English | ||
| 42166181 | Change in Director(s) | 2026-05-06 | English | ||
| 42171177 | Record Date | 2026-05-06 | English | ||
| 42171303 | Outcome of Board Meeting | 2026-05-06 | English | ||
| 42171271 | Dividend | 2026-05-06 | English | ||
| 42172778 | Press Release | 2026-05-06 | English | ||
| 42173852 | Investor Presentation | 2026-05-06 | English | ||
| 42174392 | Outcome of Board Meeting | 2026-05-06 | English | ||
| 42186784 | Analysts/Institutional Investor Meet/Con. Call Updates | 2026-04-29 | English | ||
| 42275161 | Board Meeting — Financial Results/Dividend | 2026-04-29 | English | ||
| 42275145 | Board Meeting — Board Meeting Intimation | 2026-04-29 | English | ||
| 42200408 | Copy of Newspaper Publication | 2026-04-28 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
SpyGlass Pharma, Inc.
Ophthalmic biotech developing drug delivery integrated with…
|
SGP | US | Professional, scientific and te… |
|
SQI Diagnostics Inc.
Precision medicine biotech developing innovative diagnostic…
|
SQD.H | CA | Professional, scientific and te… |
|
STARPHARMA HOLDINGS LIMITED
Develops dendrimer technology for pharmaceutical and life s…
|
SPL | AU | Professional, scientific and te… |
|
Stayble Therapeutics AB
Develops treatments for chronic pain originating from spina…
|
STABL | SE | Professional, scientific and te… |
|
STCUBE
Develops immuno-oncology therapies targeting novel immune c…
|
052020 | KR | Professional, scientific and te… |
|
StemRIM Inc.
Develops regenerative medicine that uses the body's own ste…
|
4599 | JP | Professional, scientific and te… |
|
STRATEGIC ELEMENTS LIMITED
Develops printed electronics, autonomous systems, and AI fo…
|
SOR | AU | Professional, scientific and te… |
|
Sun Pharma Advanced Research Company Ltd.
Clinical-stage biopharmaceutical firm developing innovative…
|
SPARC | IN | Professional, scientific and te… |
|
Surrozen, Inc./DE
Develops drug candidates to selectively modulate the Wnt pa…
|
SRZN | US | Professional, scientific and te… |
|
Suven Life Sciences Ltd.
Develops novel therapeutic agents for Central Nervous Syste…
|
SUVEN | IN | Professional, scientific and te… |
Vimta Labs Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/61730/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=61730 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=61730 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=61730 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 61730}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Vimta Labs Ltd. (id: 61730)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.